Volume 23, Supplement—December 2017
Global Health Security Supplement
Prioritizing Zoonoses for Global Health Capacity Building—Themes from One Health Zoonotic Disease Workshops in 7 Countries, 2014–2016
|Disease ranking criteria||No. countries||Average assigned weight† (range)|
|Economic, environmental, and/or social impact||7||0.193 (0.150–0.210)|
|Economic impact only||3|
|Economic and/or social impact||2|
|Economic, environmental, and/or social impact
|Availability of interventions (i.e., vaccines and/or medical treatment)
|Epidemic/pandemic potential (and/or sustained transmission in humans)||6||0.202 (0.170–0.220)|
|Human-to-human transmission potential||5|
|History of previous outbreaks
|Severity of disease in humans||6||0.206 (0.180–0.230)|
|Morbidity and/or mortality rate
|Presence of disease in country and/or region||5||0.200 (0.170–0.210)|
|Human and/or animal cases of illness reported in country and/or region‡||4|
|Human or animal disease prevalence and distribution in country
|Laboratory capacity/diagnostic testing capacity
|Existing multisectoral collaboration
|Mode of transmission||1||NA|
*Countries: Thailand, Kenya, Ethiopia, Azerbaijan, Cameroon, South Africa, Democratic Republic of the Congo. NA, not applicable.
†Thailand was excluded from this weighting analysis since the method used in this pilot workshop differed from the standard method adopted for all future workshops.
‡One country looked at human cases only; the other 3 looked at both human and animal cases.